Angelia Jolie Surgery Pushes Myriad Genetics, Inc. (MYGN) Into Spotlight
5/15/2013 7:49:13 AM
More...
|
Myriad Genetics, Inc. (MYGN) to Present at the Bank of America (BAC) Merrill LynchHealth Care Conference
5/14/2013 9:12:11 AM
More...
|
Myriad Genetics, Inc. (MYGN) Announces 2013 Analyst and Investor Day
5/3/2013 10:22:33 AM
More...
|
Myriad Genetics, Inc. (MYGN) to Announce Third Fiscal Quarter 2013 Results on Tuesday, May 7, 2013
4/19/2013 11:17:48 AM
More...
|
Myriad Genetics, Inc. (MYGN) Partners With PharmaMar S.A. for New HRD Test
3/29/2013 8:23:55 AM
More...
|
Myriad Genetics, Inc. (MYGN)'s Prolaris(R) Test Predicts Risk of Prostate Cancer Recurrence in Fourth Peer Reviewed Study
3/5/2013 11:26:52 AM
More...
|
Myriad Genetics, Inc. (MYGN) to Announce Second Fiscal Quarter 2013 Results on Tuesday, February 5, 2013
1/16/2013 9:21:09 AM
More...
|
Myriad Genetics, Inc. (MYGN) to Present at the 2013 J.P. Morgan Annual Healthcare Conference
12/18/2012 8:52:22 AM
More...
|
Myriad Genetics, Inc. (MYGN) Announces Diabetes Collaboration With Sanofi (France) (SAN.PA)
12/11/2012 7:08:17 AM
More...
|
Myriad Genetics, Inc. (MYGN)' HRD Test Predicts Response to Platinum Therapy in Triple-Negative Breast Cancer
12/10/2012 9:15:09 AM
More...
|
|